{"id":"urinary-fsh","safety":{"commonSideEffects":[{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Abdominal pain/bloating"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FSH (follicle-stimulating hormone) is a gonadotropin that binds to FSH receptors on ovarian granulosa cells, promoting follicular growth and maturation. The urinary-derived formulation provides bioactive FSH for controlled ovarian stimulation in assisted reproductive technology cycles. This leads to development of multiple ovarian follicles and increased estrogen levels necessary for egg retrieval.","oneSentence":"Urinary FSH is a purified preparation of follicle-stimulating hormone extracted from human urine that stimulates follicle development and estrogen production in women undergoing fertility treatment.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:39:20.690Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ovarian stimulation in assisted reproductive technology (ART) cycles"},{"name":"Anovulation and infertility in women"}]},"trialDetails":[{"nctId":"NCT07346235","phase":"PHASE3","title":"150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial","status":"NOT_YET_RECRUITING","sponsor":"American Hospital 2 Kosovo","startDate":"2026-03-01","conditions":"Infertility, Female","enrollment":440},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":"OVARIAN STIMULATION, Telomere Length, Telomere Length, Mean Leukocyte","enrollment":10},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":"Fertility Issues","enrollment":30},{"nctId":"NCT06618703","phase":"NA","title":"Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Angers","startDate":"2025-03","conditions":"Endocrine; Deficiency, Hypothalamo-Pituitary Disorder, Radiotherapy Side Effect","enrollment":230},{"nctId":"NCT06729359","phase":"","title":"Polycystic Ovary Syndrome and Urinary Tract Stones: a BMI-Adjusted Analysis in Iraqi Women","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2024-07-01","conditions":"PCOS (Polycystic Ovary Syndrome), Stone, Urinary, BMI","enrollment":407},{"nctId":"NCT05936840","phase":"","title":"Quantum Menstrual Health Monitoring Study","status":"RECRUITING","sponsor":"Quanovate Tech Inc.","startDate":"2024-05-01","conditions":"Menstrual Cycle Abnormal, Polycystic Ovary Syndrome, Athletes","enrollment":150},{"nctId":"NCT02890082","phase":"PHASE2","title":"Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2014-02","conditions":"Breast Cancer","enrollment":102},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT06145061","phase":"","title":"Evaluation on Biological Characteristics of Acupoints in Premature Ovarian Insufficiency","status":"RECRUITING","sponsor":"Xiaomei Shao","startDate":"2023-03-01","conditions":"Premature Ovarian Insufficiency","enrollment":150},{"nctId":"NCT06109623","phase":"","title":"Correlation Between Changes in Sex Hormone Levels and Stress Urinary Incontinence in Women","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2023-11-15","conditions":"Urinary Incontinence,Stress","enrollment":1226},{"nctId":"NCT05864937","phase":"","title":"C677T Methylenetetrahydrofolate Reductase Mutation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2011-12-01","conditions":"Mutation","enrollment":363},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":"Infertility","enrollment":120},{"nctId":"NCT05576740","phase":"","title":"Influence of Menstrual Cycle Stages on Female Athletes","status":"COMPLETED","sponsor":"Universitat Jaume I","startDate":"2022-03-16","conditions":"Menstrual Cycle, Sports","enrollment":41},{"nctId":"NCT05370794","phase":"","title":"Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-04-19","conditions":"In Vitro Maturation of Oocytes","enrollment":35},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT01354886","phase":"PHASE1","title":"Single Dose FSH-GEX™ in Healthy Volunteers","status":"COMPLETED","sponsor":"Glycotope GmbH","startDate":"2011-04","conditions":"Female Infertility","enrollment":19},{"nctId":"NCT01477073","phase":"PHASE1","title":"Multiple Dose FSH-GEX(TM) in Healthy Volunteers","status":"COMPLETED","sponsor":"Glycotope GmbH","startDate":"2011-10","conditions":"Female Infertility","enrollment":57},{"nctId":"NCT01058252","phase":"","title":"Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF","status":"UNKNOWN","sponsor":"Galaxy Pharma (Pvt) Limited","startDate":"2021-05","conditions":"Primary Infertility, Secondary Infertility, Low Responders","enrollment":30},{"nctId":"NCT03373149","phase":"PHASE2","title":"Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response","status":"UNKNOWN","sponsor":"Riyadh Fertility and Reproductive Health center","startDate":"2017-11-29","conditions":"Infertility, Female","enrollment":228},{"nctId":"NCT04209881","phase":"","title":"Ovarian Reserve and Ankylosing Spondylitis","status":"COMPLETED","sponsor":"Kanuni Sultan Suleyman Training and Research Hospital","startDate":"2019-12-19","conditions":"Ovarian Diseases, Ankylosing Spondylitis, Anti-Mullerian Hormone Deficiency","enrollment":50},{"nctId":"NCT04268927","phase":"PHASE2","title":"Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-04-01","conditions":"Infertility","enrollment":106},{"nctId":"NCT02821819","phase":"PHASE4","title":"Random-start Ovarian Stimulation in Egg-donors (ROSE)","status":"TERMINATED","sponsor":"Instituto Bernabeu","startDate":"2017-01-10","conditions":"Infertility","enrollment":15},{"nctId":"NCT03868202","phase":"PHASE2","title":"Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol","status":"UNKNOWN","sponsor":"Eastern Virginia Medical School","startDate":"2019-07-03","conditions":"Follicle Stimulating Hormone Glycosylation, Urinary FSH21/FSH24 Ratio, Estradiol Effect","enrollment":10},{"nctId":"NCT03935503","phase":"","title":"COMPARISON OF LAPAROSCOPIC TOTAL EXTRAPERITONEAL HERNIA REPAIR AND LICHTENSTEIN HERNIA REPAIR","status":"COMPLETED","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2017-07-01","conditions":"Inguinal Hernia","enrollment":42},{"nctId":"NCT01882166","phase":"NA","title":"Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2013-10","conditions":"Infertility, Female","enrollment":20},{"nctId":"NCT02625532","phase":"NA","title":"Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2015-12","conditions":"Reproductive Techniques, Assisted","enrollment":60},{"nctId":"NCT02625519","phase":"PHASE4","title":"Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2015-12","conditions":"Reproductive Techniques, Assisted","enrollment":180},{"nctId":"NCT02304536","phase":"PHASE3","title":"Comparison Between Laparoscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2014-11","conditions":"Infertility","enrollment":210},{"nctId":"NCT02304107","phase":"PHASE3","title":"Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-05","conditions":"Infertility","enrollment":140},{"nctId":"NCT02333253","phase":"PHASE3","title":"Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-01","conditions":"Other Complications Associated With Artificial Fertilization","enrollment":60},{"nctId":"NCT01653743","phase":"PHASE3","title":"Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2012-09","conditions":"Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction","enrollment":81},{"nctId":"NCT01206803","phase":"","title":"Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2010-09","conditions":"Infertility, Subfertility","enrollment":294},{"nctId":"NCT02503605","phase":"PHASE4","title":"Biosimilar Versus Urinary Gonadotropins","status":"UNKNOWN","sponsor":"IVI Madrid","startDate":"2015-10","conditions":"Infertility","enrollment":130},{"nctId":"NCT01204840","phase":"PHASE2","title":"Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Ottawa Fertility Centre","startDate":"2010-09","conditions":"Infertility, Poor Ovarian Reserve","enrollment":38},{"nctId":"NCT02437032","phase":"PHASE4","title":"Gonadotropin Type in Ovarian Stimulation","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2009-04","conditions":"Infertility","enrollment":100},{"nctId":"NCT00335725","phase":"PHASE3","title":"Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2003-03","conditions":"Infertility","enrollment":151},{"nctId":"NCT01504139","phase":"PHASE4","title":"The Luteal Phase After GnRHa Trigger - a Proof of Concept Study","status":"COMPLETED","sponsor":"Regionshospitalet Viborg, Skive","startDate":"2012-01","conditions":"Progesterone Levels, Infertility","enrollment":93},{"nctId":"NCT02310074","phase":"PHASE4","title":"Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2010-01","conditions":"Idiopathic Hypogonadotropic Hypogonadism","enrollment":76},{"nctId":"NCT02237755","phase":"PHASE2, PHASE3","title":"Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.","status":"UNKNOWN","sponsor":"University of Athens","startDate":"2014-10","conditions":"Female Infertility","enrollment":50},{"nctId":"NCT02237781","phase":"PHASE2, PHASE3","title":"Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins","status":"UNKNOWN","sponsor":"University of Athens","startDate":"2014-10","conditions":"Female Infertility","enrollment":50},{"nctId":"NCT02099916","phase":"PHASE2, PHASE3","title":"Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF","status":"UNKNOWN","sponsor":"University of Athens","startDate":"2014-10","conditions":"Efficacy of DHEA, Pregnancy Rate, Diminished Ovarian Reserve","enrollment":50},{"nctId":"NCT01735422","phase":"PHASE2","title":"A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"1999-12","conditions":"Infertility","enrollment":67},{"nctId":"NCT01185782","phase":"PHASE3","title":"SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-02","conditions":"Infertility, Ovulation Induction","enrollment":300},{"nctId":"NCT01212263","phase":"NA","title":"Clomiphene Citrate (CC) Co-treatment With HP Urinary FSH vs HP Urinary FSH in CC-resistant PCOS","status":"COMPLETED","sponsor":"Mansoura Integrated Fertility Center","startDate":"2010-01","conditions":"Polycystic Ovary Syndrome","enrollment":174},{"nctId":"NCT00502281","phase":"PHASE4","title":"Controlled Ovarian Stimulation Followed by Timed Intercourse or Intrauterine Insemination in Infertile PCOS Patients","status":"SUSPENDED","sponsor":"University Magna Graecia","startDate":"2007-01","conditions":"Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT00502229","phase":"PHASE4","title":"Therapy for Infertile PCOS Patients Ovulating Under Clomiphene Citrate or Metformin","status":"WITHDRAWN","sponsor":"University Magna Graecia","startDate":"2010-01","conditions":"Polycystic Ovary Syndrome, Infertility","enrollment":""},{"nctId":"NCT01250314","phase":"NA","title":"Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-02","conditions":"Osteoporosis","enrollment":79},{"nctId":"NCT01623570","phase":"NA","title":"Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP","status":"COMPLETED","sponsor":"Centro Riproduzione e Andrologia","startDate":"2011-03","conditions":"Hypogonadotropic Hypogonadism","enrollment":40},{"nctId":"NCT01219153","phase":"PHASE2","title":"Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET","status":"COMPLETED","sponsor":"Cairo University","startDate":"2008-09","conditions":"Infertility","enrollment":136},{"nctId":"NCT00677573","phase":"NA","title":"Efficacy of Urinary Follicle-Stimulating Hormone (FSH) Among Poor Responders","status":"UNKNOWN","sponsor":"German Hospital, Istanbul","startDate":"2008-05","conditions":"Infertility","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"CYSTOSARCOMA PHYLLODES"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Fostipur","Bravelle"],"phase":"marketed","status":"active","brandName":"Urinary FSH","genericName":"Urinary FSH","companyName":"IVI Madrid","companyId":"ivi-madrid","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Urinary FSH is a purified preparation of follicle-stimulating hormone extracted from human urine that stimulates follicle development and estrogen production in women undergoing fertility treatment. Used for Ovarian stimulation in assisted reproductive technology (ART) cycles, Anovulation and infertility in women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}